Free Trial

More results...

Filter by Content types
Market profile database
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
News analysis
Pricing snapshots
Brand price trackers
Flavour tracker
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Switzerland Event next week will inform industry about new tobacco legislation ...
  • Bulgaria Public invited to comment on new legal definition of e-liquids ...
  • Denmark Bill on extended producer responsibility for packaging notified to TRIS ...
  • Europe European Ombudsman holds workshop on tobacco lobbying ...
  • Philippines BIR regulations update floor prices of vaping products ...
  • Germany Politicians against advertising and tax exceptions for tobacco alternatives ...
  • Italy Enquiry launched into taxation and licensing system for retail sale of novel nicotine products ...
  • Malta List of notified e-cigs and refill containers updated ...
  • Europe EU Commission proposes extending restrictions of smoke-free environments to vaping ...
  • Australia Queensland toughens sanctions for sale of illicit vapes ...
  • Malaysia Health groups demand implementation of smoking law by October ...
  • Philippines Sales of four more vape brands halted over fiscal marking violations ...
View all
Resources

Bundesinstitut für Arzneimittel und Medizinprodukt (BfArM) (The Federal Institute for Drugs and Medical Devices)

Written by || 31st March 2014 || Resources | Health and science | Policy and Politics | Regulation and Legislation | Europe Germany

An independent federal higher authority within the portfolio of the Federal Ministry of Health. At the BfArM,  (physicians, pharmacists, chemists, biologists, lawyers, engineers, technical assistants, administrative staff etc.) are involved in the tasks of licensing, improving the safety of medicinal products, detecting and evaluating the risks of medical devices, and monitoring the legal traffic in narcotic drugs and precursors. The » Continue Reading.
Try ECigIntelligence
I'm already a subscriber

Login

Author default picture

ECigIntelligence

This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.